Comprehensive molecular characterization of gastric adenocarcinoma

Nature

Volumn 513, Issue 7517, 2014, Pages 202-209

  Bass, Adam J ^a   Thorsson, Vesteinn ^b   Shmulevich, Ilya ^b   Reynolds, Sheila M ^b   Miller, Michael ^b   Bernard, Brady ^b   Hinoue, Toshinori ^c   Laird, Peter W ^c   Curtis, Christina ^d   Shen, Hui ^c   Weisenberger, Daniel J ^c   Schultz, Nikolaus ^e   Shen, Ronglai ^e   Weinhold, Nils ^e   Kelsen, David P ^e   Bowlby, Reanne ^f   Chu, Andy ^f   Kasaian, Katayoon ^f   Mungall, Andrew J ^f   Robertson, A Gordon ^f   Sipahimalani, Payal ^f   Cherniack, Andrew D ^g   Getz, Gad ^g   Liu, Yingchun ^g   Noble, Michael S ^g   Pedamallu, Chandra ^g   Sougnez, Carrie ^g   Taylor Weiner, Amaro ^g   Akbani, Rehan ^h   Lee, Ju Seog ^h   Liu, Wenbin ^h   Mills, Gordon B ^h   Yang, Da ^h   Zhang, Wei ^h   Pantazi, Angeliki ⁱ   Parfenov, Michael ⁱ   Gulley, Margaret ^j   Piazuelo, M Blanca ^k   Schneider, Barbara G ^k   Kim, Jihun ^l   Boussioutas, Alex ^m   Sheth, Margi ⁿ   Demchok, John A ⁿ   Rabkin, Charles S ⁿ   Willis, Joseph E ^o   Ng, Sam ^p   Garman, Katherine ^q   Beer, David G ^r   Pennathur, Arjun ^s   Raphael, Benjamin J ^t   Wu, Hsin Ta ^t   Odze, Robert ^u   Kim, Hark K ^v   Bowen, Jay ^w   Leraas, Kristen M ^w   Lichtenberg, Tara M ^w   Weaver, Stephanie ^w   McLellan, Michael ^x   Wiznerowicz, Maciej ^y   Sakai, Ryo ^z   Lawrence, Michael S ^g   Cibulskis, Kristian ^g   Lichtenstein, Lee ^g   Fisher, Sheila ^g   Gabriel, Stacey B ^g   Lander, Eric S ^g   Ding, Li ^x   Niu, Beifang ^x   Ally, Adrian ^f   Balasundaram, Miruna ^f   Birol, Inanc ^f   Brooks, Denise ^f   Butterfield, Yaron S N ^f   Carlsen, Rebecca ^f   Chu, Justin ^f   Chuah, Eric ^f   Chun, Hye Jung E ^f   Clarke, Amanda ^f   Dhalla, Noreen ^f   Guin, Ranabir ^f   Holt, Robert A ^f   Jones, Steven J M ^f   Lee, Darlene ^f   Li, Haiyan A ^f   Lim, Emilia ^f   Ma, Yussanne ^f   Marra, Marco A ^f   Mayo, Michael ^f   Moore, Richard A ^f   Mungall, Karen L ^f   Nip, Ka Ming ^f   Schein, Jacqueline E ^f   Tam, Angela ^f   Thiessen, Nina ^f   Beroukhim, Rameen ^g   Carter, Scott L ^g   Cho, Juok ^g   DiCara, Daniel ^g   Frazer, Scott ^g   Gehlenborg, Nils ^g   Heiman, David I ^g   Jung, Joonil ^g   Kim, Jaegil ^g   Lin, Pei ^g   Meyerson, Matthew ^g   Ojesina, Akinyemi I ^g   Pedamallu, Chandra Sekhar ^g   Saksena, Gordon ^g   Schumacher, Steven E ^g   Stojanov, Petar ^g   Tabak, Barbara ^g   Voet, Doug ^g   Rosenberg, Mara ^g   Zack, Travis I ^g   Zhang, Hailei ^g   Zou, Lihua ^g   Protopopov, Alexei ^h   Santoso, Netty ⁱ   Lee, Semin ^aa   Zhang, Jianhua ^h   Mahadeshwar, Harshad S ^h   Tang, Jiabin ^h   Ren, Xiaojia ⁱ   Seth, Sahil ^h   Yang, Lixing ^aa   Xu, Andrew W ^aa   Song, Xingzhi ^h   Xi, Ruibin ^aa   Bristow, Christopher A ^h   Hadjipanayis, Angela ⁱ   Seidman, Jonathan ⁱ   Chin, Lynda ^h   Park, Peter J ^aa   Kucherlapati, Raju ⁱ   Ling, Shiyun ^h   Rao, Arvind ^h   Weinstein, John N ^h   Kim, Sang Bae ^h   Lu, Yiling ^h   Bootwalla, Moiz S ^c   Lai, Phillip H ^c   Triche, Timothy ^c   Van Den Berg, David J ^c   Baylin, Stephen B ^ab   Herman, James G ^ab   Murray, Bradley A ^g   Askoy, B Arman ^e   Ciriello, Giovanni ^e   Dresdner, Gideon ^e   Gao, Jianjiong ^e   Gross, Benjamin ^e   Jacobsen, Anders ^e   Lee, William ^e   Ramirez, Ricardo ^e   Sander, Chris ^e   Senbabaoglu, Yasin ^e   Sinha, Rileen ^e   Sumer, S Onur ^e   Sun, Yichao ^e   Iype, Lisa ^b   Kramer, Roger W ^b   Kreisberg, Richard ^b   Rovira, Hector ^b   Tasman, Natalie ^b   Haussler, David ^p   Stuart, Josh M ^p   Verhaak, Roeland G W ^h   Leiserson, Mark D M ^t   Taylor, Barry S ^ac   Black, Aaron D ^w   Carney, Julie Ann ^w   Gastier Foster, Julie M ^w   Helsel, Carmen ^w   McAllister, Cynthia ^w   Ramirez, Nilsa C ^w   Tabler, Teresa R ^w   Wise, Lisa ^w   Zmuda, Erik ^w   Penny, Robert ^ad   Crain, Daniel ^ad   Gardner, Johanna ^ad   Lau, Kevin ^ad   Curely, Erin ^ad   Mallery, David ^ad   Morris, Scott ^ad   Paulauskis, Joseph ^ad   Shelton, Troy ^ad   Shelton, Candace ^ad   Sherman, Mark ^ad   Benz, Christopher ^ae   Lee, Jae Hyuk ^af   Fedosenko, Konstantin ^ag   Manikhas, Georgy ^ag   Potapova, Olga ^ah   Voronina, Olga ^ah   Belyaev, Dmitry ^ah   Dolzhansky, Oleg ^ah   Rathmell, W Kimryn ^j   Brzezinski, Jakub ^y   Ibbs, Matthew ^y   Korski, Konstanty ^y   Kycler, Witold ^y   Łaźniak, Radoslaw ^y   Leporowska, Ewa ^y   Mackiewicz, Andrzej ^y   Murawa, Dawid ^y   Murawa, Pawel ^y   Spychała, Arkadiusz ^y   Suchorska, Wiktoria M ^y   Tatka, Honorata ^y   Teresiak, Marek ^y   Abdel Misih, Raafat ^ai   Bennett, Joseph ^ai   Brown, Jennifer ^ai   Iacocca, Mary ^ai   Rabeno, Brenda ^ai   Kwon, Sun Young ^aj   Kemkes, Ariane ^ad   Curley, Erin ^ad   Alexopoulou, Iakovina ^ak   Engel, Jay ^al   Bartlett, John ^am   Albert, Monique ^am   Park, Do Youn ^an   Dhir, Rajiv ^s   Luketich, James ^s   Landreneau, Rodney ^s   Janjigian, Yelena Y ^e   Cho, Eunjung ^e   Ladanyi, Marc ^e   Tang, Laura ^e   McCall, Shannon J ^q   Park, Young S ^l   Cheong, Jae Ho ^ao   Ajani, Jaffer ^h   Camargo, M Constanza ⁿ   Alonso, Shelley ^ap   Ayala, Brenda ^ap   Jensen, Mark A ^ap   Pihl, Todd ^ap   Raman, Rohini ^ap   Walton, Jessica ^ap   Wan, Yunhu ^ap   Eley, Greg ⁿ   Shaw, Kenna R Mills ⁿ   Tarnuzzer, Roy ⁿ   Wang, Zhining ⁿ   Yang, Liming ⁿ   Zenklusen, Jean Claude ⁿ   Davidsen, Tanja ⁿ   Hutter, Carolyn M ^aq   Sofia, Heidi J ^aq   Burton, Robert ^ar   Chudamani, Sudha ^ar   Liu, Jia ^ar   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l University of Ulsan College of Medicine   (South Korea)

^m UNIVERSITY OF MELBOURNE   (Australia)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

^o CASE WESTERN RESERVE UNIVERSITY   (United States)

^p University of California Santa Cruz   (United States)

^q DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^s UNIVERSITY OF PITTSBURGH   (United States)

^t Brown Univerity   (United States)

^u BRIGHAM AND WOMEN S HOSPITAL   (United States)

^v National Cancer Center   (South Korea)

^w THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^x WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y GREATER POLAND CANCER CENTRE   (Poland)

^z UNIVERSITY OF LEUVEN   (Belgium)

^aa Harvard Medical School Center for Biomedical Informatics   (United States)

^ab JOHNS HOPKINS UNIVERSITY   (United States)

^ac UNIVERSITY OF CALIFORNIA   (United States)

^ad International Genomics Consortium   (United States)

^ae BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^af Chonnam National University Medical School   (South Korea)

^ag City Oncology Dispensary   (Russian Federation)

^ah Cureline Inc   (United States)

^ai HELEN F GRAHAM CANCER CENTER   (United States)

^aj Keimyung University School of Medicine   (South Korea)

^ak MCMASTER UNIVERSITY   (Canada)

^al KINGSTON GENERAL HOSPITAL   (Canada)

^am ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^an Pusan National University Hospital   (South Korea)

^ao Yonsei University College of Medicine   (South Korea)

^ap GENERAL DYNAMICS   (United States)

^aq NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^ar SAIC FREDERICK INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; JANUS KINASE 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROTEIN TYROSINE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEOME;

CANCER; DIGESTIVE SYSTEM DISORDER; MOLECULAR ANALYSIS;

ANEUPLOIDY; ARTICLE; CANCER CLASSIFICATION; CHROMOSOMAL INSTABILITY; DNA METHYLATION; EPSTEIN BARR VIRUS INFECTION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MOLECULAR PATHOLOGY; MUTATION RATE; PIK3CA GENE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; CLASSIFICATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; ISOLATION AND PURIFICATION; MALE; MUTATION; STOMACH TUMOR; VIROLOGY;

HUMAN HERPESVIRUS 4;

ADENOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MUTATION; PROTEOME; STOMACH NEOPLASMS;

EID: 84907270779     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13480     Document Type: Article

References (41)

1. Ferlay, J. et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase 11, http://globocan.iarc.fr, accessed on January 15, 2014 (2013).
2. Laurén, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol., Microbiol. Scand. 64, 31-49 (1965).
3. th edn (International Agency for Research on Cancer, 2010).
4. Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789 (2001).
5. Bertuccio, P. et al. Recent patterns in gastric cancer: a global overview. International J. Cancer 125, 666-673 (2009).
6. Richards, F. M. et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum.Mol. Genet. 8, 607-610 (1999).
7. Keller, G. et al. Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. International J Cancer 68, 571-576 (1996).
8. Toyota, M. et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438-5442 (1999).
9. Tan, I. B. et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141, 476-485 (2011).
10. Lei, Z. et al. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology 145, 554-565 (2013).
11. Boussioutas, A. et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 63, 2569-2577 (2003).
12. Wang, K. et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nature Genet. 43, 1219-1223 (2011).
13. Shen, R., Olshen, A. B.&Ladanyi, M. Integrative clustering ofmultiple genomicdata types using a joint latent variablemodel with application to breast and lung cancer subtype analysis. Bioinformatics 25, 2906-2912 (2009).
14. Murphy, G., Pfeiffer, R., Camargo, M. C. & Rabkin, C. S. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137, 824-833 (2009).
15. Matsusaka, K. et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 71, 7187-7197 (2011).
16. Geddert, H., Zur Hausen, A., Gabbert, H. E. & Sarbia, M. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1. Anal. Cell. Pathol. 33, 143-149 (2010).
17. Lee, J. et al. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS ONE 7, e38892 (2012).
18. Sukawa, Y. et al. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer. World J. Gastroenterology 18, 6577-6586 (2012).
19. Strong, M. J. et al. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog. 9, e1003341 (2013).
20. The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
21. Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73 (2013).
22. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
23. Bernal, M., Ruiz-Cabello, F., Concha, A., Paschen, A. & Garrido, F. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol. Immunother. 61, 1359-1371 (2012).
24. Greulich, H. et al. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc. Natl Acad. Sci. USA 109, 14476-14481 (2012).
25. Grossmann, V. et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 118, 6153-6163 (2011).
26. Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106-110 (2012).
27. Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet. 45, 478-486 (2013).
28. Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science 302, 1704-1709 (2003).
29. Thumkeo, D., Watanabe, S. & Narumiya, S. Physiological roles of Rho and Rho effectors in mammals. Eur. J. Cell Biol. 92, 303-315 (2013).
30. Aznar, S. et al. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol. Biol. Cell 12, 3282-3294 (2001).
31. Yu, H. & Jove, R. The STATs of cancer-new molecular targets come of age. Nature Rev. Cancer 4, 97-105 (2004).
32. Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nature Genet. 46, 166-170 (2014).
33. Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nature Genet. 46, 171-175 (2014).
34. Doherty, G. J. et al. The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. Mol. Biol. Cell 22, 4380-4389 (2011).
35. Joneson, T., White, M. A., Wigler, M. H. & Bar-Sagi, D. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271, 810-812 (1996).
36. Türeci, O. et al. Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. Gene 481, 83-92 (2011).
37. Chen, B. J. et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clinical Cancer Res 19, 3462-3473 (2013).
38. Green, M. R. et al. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clinical Cancer Res 18, 1611-1618 (2012).
39. The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
40. Fuchs, C. S. et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 383, 31-39 (2014).
41. Schaefer, C. F. et al. PID: the pathway interaction database. Nucleic Acids Res. 37, D674-D679 (2009).